Sandy Kaufhold
8 Papers
Sandy Kaufhold is an academic researcher. The author has contributed to research in topics: Internal medicine & Breast cancer. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
PIK3CA-mutations in breast cancer
K. Reinhardt,K Stückrath,Carolin Hartung,Sandy Kaufhold,Christoph Uleer,Volker Hanf,T Lantzsch,Susanne Peschel,Jutta John,Marleen Pöhler,Marcus Bauer,Friedrich Karl Bürrig,Edith Weigert,J. Buchmann,Eva Johanna Kantelhardt,Christoph Thomssen,Martina Vetter +16 more
TL;DR: In this article , the prevalence of PIK3CA-mutations in a cohort of early stage breast cancer patients and the association to the course of disease was determined by qPCR.
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
Kathleen Schüler,Daniel Bethmann,Sandy Kaufhold,Carolin Hartung,K Stückrath,T Lantzsch,Christoph Uleer,Volker Hanf,Susanne Peschel,Jutta John,Marleen Pöhler,J. Buchmann,Karl-Friedrich Bürrig,Edith Weigert,Christoph Thomssen,Eva Johanna Kantelhardt,Martina Vetter +16 more
TL;DR: Tumour-infiltrating lymphocytes bore prognostic value, especially in HER2-positive breast cancer, and additional research on the components of immune infiltration might be reasonable for clinical use.
Abstract P1-11-11: HER2-directed therapy in early breast cancer – improvement over 20 years
Christoph Thomssen,Julia H. Engel,K. Reinhardt,A. Strauss,R. Grosse,Susanne Barrot,Marcus Bauer,Lisa van Uden,Sandy Kaufhold,Kathleen Schüler,Vanessa Wieder,Eva Johanna Kantelhardt,Martina Vetter +12 more
TL;DR: For example, Thomssen et al. as discussed by the authors developed a consecutive tumor and data base from 2000 to 2020 and identified patients with early HER2-positive breast cancer (n=396).
Abstract P3-11-07: HER2 determination by ERBB2-mRNA expression analysis
M. Vetter,Lara Bender,Marcus Bauer,Sandy Kaufhold,Volker Hanf,Christoph Uleer,T Lantzsch,S. Peschel,Jutta John,Marleen Pöhler,Edith Weigert,J. Buchmann,Markus Wallwiener,E. Kantelhardt,C. Thomssen +14 more
Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel,V. Wieder,Marcus Bauer,Sandy Kaufhold,K Stückrath,Jochen Wilke,Volker Hanf,Christoph Uleer,T Lantzsch,S. Peschel,Jutta John,Marleen Pöhler,Edith Weigert,K-F. Bürrig,Jörg Buchmann,Pablo Santos,Eva Johanna Kantelhardt,Christoph Thomssen,Martina Vetter +18 more
TL;DR: This study investigates the prognostic and predictive value of NOTCH1 mRNA expression in early breast cancer, finding high expression associated with negative hormone receptor status, high uPA/PAI-1 status, and increased recurrence-free interval events, suggesting NOTCH1 as a potential biomarker for personalized therapy.